187 related articles for article (PubMed ID: 31242986)
1. Malignant Pleural Mesothelioma: A Multi-Disciplinary Approach.
Mansha MA; Ali N; Ali S; Azam N; Khan AMH
Gulf J Oncolog; 2019 May; 1(30):76-80. PubMed ID: 31242986
[TBL] [Abstract][Full Text] [Related]
2. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
3. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
[TBL] [Abstract][Full Text] [Related]
4. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
Rimner A; Spratt DE; Zauderer MG; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Adusumilli P; Rusch VW; Krug LM
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):394-401. PubMed ID: 25073664
[TBL] [Abstract][Full Text] [Related]
5. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
[TBL] [Abstract][Full Text] [Related]
6. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for malignant pleural mesothelioma.
Rosenzweig KE; Giraud P
Cancer Radiother; 2017 Feb; 21(1):73-76. PubMed ID: 28237609
[TBL] [Abstract][Full Text] [Related]
8. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
Spatola C; Militello C; Tocco A; Salamone V; Raffaele L; Migliore M; Pagana A; Milazzotto R; Chillura I; Pergolizzi S; Privitera G
Future Oncol; 2016 Dec; 12(23s):67-71. PubMed ID: 27651129
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma.
Simon M; Shochat T; Peled N; Zer A; Kramer MR; Eldan O; Saute M; Dudnik ER; Allen AM
Thorac Cancer; 2018 Nov; 9(11):1470-1475. PubMed ID: 30240138
[TBL] [Abstract][Full Text] [Related]
12. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma.
Matsuo Y; Shibuya K; Okubo K; Ueki N; Aoyama A; Sonobe M; Nakamura M; Mizowaki T; Date H; Hiraoka M
Acta Oncol; 2017 Jul; 56(7):957-962. PubMed ID: 28117611
[TBL] [Abstract][Full Text] [Related]
15. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
Shaaban SG; Verma V; Choi JI; Shabason J; Sharma S; Glass E; Grover S; Badiyan SN; Simone CB
Clin Lung Cancer; 2018 Sep; 19(5):e685-e692. PubMed ID: 29803576
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma.
Krayenbuehl J; Dimmerling P; Ciernik IF; Riesterer O
Radiat Oncol; 2014 Jan; 9():32. PubMed ID: 24456714
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy with simultaneous integrated boost in unresected left-sided pleural mesothelioma: a case report.
Cilla S; Digesú C; Silvano G; Macchia G; Massaccesi M; Deodato F; Padula GD; Fidanzio A; Piermattei A; Morganti AG
Tumori; 2010; 96(4):618-22. PubMed ID: 20968144
[TBL] [Abstract][Full Text] [Related]
19. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
[TBL] [Abstract][Full Text] [Related]
20. Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Riesterer O; Ciernik IF; Stahel RA; Xyrafas A; Aebersold DM; Plasswilm L; Mahmut Ozsahin E; Zwahlen DR; Nackaerts K; Zimmermann F; Sabrina Stark L; Weder W; Krayenbuehl J;
Radiother Oncol; 2019 Sep; 138():121-125. PubMed ID: 31252293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
